NCT05359081: An ongoing trial by Sumitomo Pharma Co., Ltd.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05359081 |
|---|---|
| Title | A 52-week, Open-label Study to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 16, 2022 |
| Completion date | March 21, 2024 |
| Required reporting date | March 21, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |